Christophe Guervilly1, Magali Bisbal2,3, Jean Marie Forel4, Malika Mechati3, Samuel Lehingue4, Jeremy Bourenne3, Gilles Perrin3, Romain Rambaud4, Melanie Adda4, Sami Hraiech4, Elisa Marchi4, Antoine Roch4,5, Marc Gainnier3, Laurent Papazian4. 1. Réanimation des Détresses Respiratoires et Infections Sévères, Hôpital Nord, Aix-Marseille Univ, Assistance Publique-Hôpitaux de Marseille, URMITE UMR CNRS 7278, Marseille, France. christophe.guervilly@ap-hm.fr. 2. Département d'anesthésie et de Réanimation, Réanimation Polyvalente, Institut Paoli-Calmettes, Marseille, France. 3. Réanimation des Urgences et Medicale, CHU la Timone 2 Marseille, Aix-Marseille Université, 13385, Marseille, France. 4. Réanimation des Détresses Respiratoires et Infections Sévères, Hôpital Nord, Aix-Marseille Univ, Assistance Publique-Hôpitaux de Marseille, URMITE UMR CNRS 7278, Marseille, France. 5. Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Service d'Accueil des Urgence, Marseille, France.
Abstract
PURPOSE: To investigate whether neuromuscular blocking agents (NMBA) exert beneficial effects in acute respiratory distress syndrome (ARDS) by reason of their action on respiratory mechanics, particularly transpulmonary pressures (P L). METHODS: A prospective randomised controlled study in patients with moderate to severe ARDS within 48 h of the onset of ARDS. All patients were monitored by means of an oesophageal catheter and followed up for 48 h. Moderate ARDS patients were randomised into two groups according to whether they were given a 48-h continuous infusion of cisatracurium besylate or not (control group). Severe ARDS patients did not undergo randomisation and all received cisatracurium besylate per protocol. The changes during the 48-h study period in oxygenation and in respiratory mechanics, including inspiratory and expiratory P L and driving pressure, were assessed and compared. Delta P L (∆P L) was defined as inspiratory P L minus expiratory P L. RESULTS:Thirty patients were included, 24 with moderate ARDS and 6 with severe ARDS. NMBA infusion was associated with an improvement in oxygenation in both moderate and severe ARDS, accompanied by a decrease in both plateau pressure and total positive end-expiratory pressure. The mean inspiratory and expiratory P L were higher in the moderate ARDS group receiving NMBA than in the control group. In contrast, there was no change in either driving pressure or ∆P L related to NMBA administration. CONCLUSIONS:NMBA could exert beneficial effects in patients with moderate ARDS, at least in part, by limiting expiratory efforts.
RCT Entities:
PURPOSE: To investigate whether neuromuscular blocking agents (NMBA) exert beneficial effects in acute respiratory distress syndrome (ARDS) by reason of their action on respiratory mechanics, particularly transpulmonary pressures (P L). METHODS: A prospective randomised controlled study in patients with moderate to severe ARDS within 48 h of the onset of ARDS. All patients were monitored by means of an oesophageal catheter and followed up for 48 h. Moderate ARDS patients were randomised into two groups according to whether they were given a 48-h continuous infusion of cisatracurium besylate or not (control group). Severe ARDS patients did not undergo randomisation and all received cisatracurium besylate per protocol. The changes during the 48-h study period in oxygenation and in respiratory mechanics, including inspiratory and expiratory P L and driving pressure, were assessed and compared. Delta P L (∆P L) was defined as inspiratory P L minus expiratory P L. RESULTS: Thirty patients were included, 24 with moderate ARDS and 6 with severe ARDS. NMBA infusion was associated with an improvement in oxygenation in both moderate and severe ARDS, accompanied by a decrease in both plateau pressure and total positive end-expiratory pressure. The mean inspiratory and expiratory P L were higher in the moderate ARDS group receiving NMBA than in the control group. In contrast, there was no change in either driving pressure or ∆P L related to NMBA administration. CONCLUSIONS: NMBA could exert beneficial effects in patients with moderate ARDS, at least in part, by limiting expiratory efforts.
Authors: F Mojoli; D Chiumello; M Pozzi; I Algieri; S Bianzina; S Luoni; C A Volta; A Braschi; L Brochard Journal: Minerva Anestesiol Date: 2015-01-30 Impact factor: 3.051
Authors: Laurent Papazian; Jean-Marie Forel; Arnaud Gacouin; Christine Penot-Ragon; Gilles Perrin; Anderson Loundou; Samir Jaber; Jean-Michel Arnal; Didier Perez; Jean-Marie Seghboyan; Jean-Michel Constantin; Pierre Courant; Jean-Yves Lefrant; Claude Guérin; Gwenaël Prat; Sophie Morange; Antoine Roch Journal: N Engl J Med Date: 2010-09-16 Impact factor: 91.245
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Fang Gao Smith; Gavin D Perkins; Simon Gates; Duncan Young; Daniel F McAuley; William Tunnicliffe; Zahid Khan; Sarah E Lamb Journal: Lancet Date: 2011-12-11 Impact factor: 79.321
Authors: Jeremy Bourenne; Christophe Guervilly; Malika Mechati; Sami Hraiech; Megan Fraisse; Magali Bisbal; Antoine Roch; Jean Marie Forel; Laurent Papazian; Marc Gainnier Journal: Intensive Care Med Date: 2019-02-28 Impact factor: 17.440
Authors: Pierre Esnault; Bertrand Prunet; Cédric Nguyen; Jean Marie Forel; Christophe Guervilly; Yongfang Zhou; Yan Kang Journal: Intensive Care Med Date: 2017-11-09 Impact factor: 17.440
Authors: Caio C A Morais; Yukiko Koyama; Takeshi Yoshida; Glauco M Plens; Susimeire Gomes; Cristhiano A S Lima; Ozires P S Ramos; Sérgio M Pereira; Naomasa Kawaguchi; Hirofumi Yamamoto; Akinori Uchiyama; João B Borges; Marcos F Vidal Melo; Mauro R Tucci; Marcelo B P Amato; Brian P Kavanagh; Eduardo L V Costa; Yuji Fujino Journal: Am J Respir Crit Care Med Date: 2018-05-15 Impact factor: 21.405
Authors: Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy Journal: Intensive Care Med Date: 2021-10-02 Impact factor: 17.440